secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0001799191-23-000048
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncology Institute regains Nasdaq minimum bid price compliance
--------------------------------------------------------------

- Received Nasdaq notice on Sept 15, 2023 confirming compliance with Listing Rule 550(a)(2).
- Common stock closing bid price was $1.00 or more for 11 consecutive business days through Sept 14.
- Company had been non-compliant since April 25, 2023; original deadline was Oct 23, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000048/0001799191-23-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000048/toi-20230915.htm
  HTML page:      https://secwatch.observer/filing/0001799191-23-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer